Parallax Volatility Advisers
XLRN

Parallax Volatility Advisers’s Acceleron Pharma XLRN Stock Holding History

Parallax Volatility Advisers’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11,391
Closed -$1.28M – 3343
2020
Q3 		$1.28M Buy
+11,391
New +$1.13M ﹤0.01% 1889
2018
Q3 		– Sell
-15,348
Closed -$754K – 3890
2018
Q2 		$745K Buy
+15,348
New +$559K ﹤0.01% 1172
2018
Q1 		– Sell
-5,712
Closed -$242K – 4823
2017
Q4 		$242K Buy
5,712
+504
+10% +$18.9K ﹤0.01% 2122
2017
Q3 		$194K Buy
5,208
+536
+11% +$18.6K ﹤0.01% 1477
2017
Q2 		$142K Buy
+4,672
New +$135K ﹤0.01% 1559

Other funds holding XLRN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Parallax Volatility Advisers's XLRN Position: Q4 2020 in Review

Parallax Volatility Advisers sold out of Acceleron Pharma (XLRN) in Q4 2020, closing a stake of 11,391 shares — an estimated $1.28M sold.

Parallax Volatility Advisers first reported a position in XLRN in Q2 2017 and held it in 5 quarters. The position peaked at $1.28M in Q3 2020. 253 funds tracked by Wall St. Rank hold XLRN as of Q4 2020.

  • Parallax Volatility Advisers reported no remaining Acceleron Pharma position as of Q4 2020 after selling out during the quarter.
  • Parallax Volatility Advisers sold 11,391 Acceleron Pharma shares in Q4 2020, an estimated $1.28M.
  • Parallax Volatility Advisers first reported a position in Acceleron Pharma in Q2 2017 and held it in 5 quarters.
  • Parallax Volatility Advisers's Acceleron Pharma position peaked at $1.28M in Q3 2020.
  • 253 funds tracked by Wall St. Rank held Acceleron Pharma as of Q4 2020.

Based on Parallax Volatility Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.